R&D
Advanced biopharmaceutical development company
Stem Cells
Stem cells are completely undifferentiated cells and are the cells of organs or tissues
that make up our body that have the ability to differentiate.
Stem cells can make various organs and tissues that make up our body, such as the brain, skin, cartilage, bones, nerves, and muscles, or regenerate damaged organs or tissues through cell division and differentiation.
By using the tissue regeneration function of these stem cells, stem cell therapy has the advantage of being able to treat symptoms more fundamentally than just improve them like existing medicines.
Our company is developing advanced biopharmaceuticals using these umbilical cord-derived stem cells, and umbilical cord-derived mesenchymal stem cells are known to have no immune rejection reaction compared to other stem cells, as well as excellent blood vessel formation ability.
By using the tissue regeneration function of these stem cells, stem cell therapy has the advantage of being able to treat symptoms more fundamentally than just improve them like existing medicines.
Our company is developing advanced biopharmaceuticals using these umbilical cord-derived stem cells, and umbilical cord-derived mesenchymal stem cells are known to have no immune rejection reaction compared to other stem cells, as well as excellent blood vessel formation ability.
-
STEM CELLS
Advanced Biopharmaceuticals
C-STEM™
The stem cell therapy under development by our company has mesenchymal stem cells derived from the umbilical cord as the main component, and development is underway with sarcopenia as the main target.
Sarcopenia causes diabetes, cardiovascular disease, and many others, and the death rate is two to 10 times higher than normal.
In Korea, it has been given a disease code for 2021, and there is no cure yet worldwide.
It is a high-tech biopharmaceutical that treats diseases by administering healthy umbilical cord-derived stem cells and using the blood vessel formation and tissue regeneration capabilities of stem cells.
It is a high-tech biopharmaceutical that treats diseases by administering healthy umbilical cord-derived stem cells and using the blood vessel formation and tissue regeneration capabilities of stem cells.
